Reliance Retail Ventures, owned by Mukesh Ambani, is planning to invest Rs 1,000-3,000 crore to acquire a majority stake in a dedicated diagnostic services firm, aiming to tap into the $150 billion healthcare sector. The company seeks a nationwide presence and plans to establish its own network of physical laboratories across India. This move follows its acquisition of online pharmacy Netmeds in 2020. With the diagnostic sector projected to grow by 10 to 11 percent in revenue by FY 2025, driven by geographic expansion and demand for preventive health packages, Reliance’s foray reflects the industry’s evolving landscape post-pandemic.